ShareXLinkedInRedditFacebookWhatsApp
PREMIUM RESEARCH REPORT
Outlook: Bullish

Ecolab (ECL) In-Depth Stock Report

A water, hygiene, and infection prevention leader with recurring service revenue, priced on consistent growth and margin expansion.

Published 2026-09-21·Updated 2026-09-21·Basic MaterialsSpecialty Chemicals

Investment Summary

Every headline number this report produces, collected in one place before the analysis that derives them. All figures are computed live at page load, so this block reflects the market as of the moment you opened the page.

Current Price
$269.98
Outlook
Bullish
(directional lean, see note below)
Valuation Verdict
Above fair value
(vs. our relevance-weighted range)
Fair Value Range
$36 – $213
12-Month Price Target
$306.51
(model + consensus blend)
Expected Return to Target
+13.5%
AI Score
42 / 100
(vs. our covered universe)
Risk Rating
Low
(risk factor 74/100, lower is riskier)
Target Confidence
High
Horizon
12 months
(target and scenarios)
Why we hold this view
  • Pricing and volume grow steadily.
  • Margins keep expanding.
  • Water and data center applications grow.
  • Digital services scale.
"Outlook" is a plain-language summary of our expected return to the 12-month price target (Bullish ≥ 8% upside, Bearish ≤ 8% downside, Neutral in between; falls back to the fair-value comparison when no target is available) — it is a restatement of the figures above, not a new signal, and like them is not a buy or sell recommendation. "Valuation Verdict" compares the live price to our relevance-weighted fair-value range and is a statement about our own model's output, not a buy or sell recommendation — see the Investor Decision Framework near the end of this report. The risk rating is derived from AI Score risk factor rather than assigned by hand. Expected return measures the gap to the 12-month blended target only; it is not a forecast of total return and excludes any dividend.
ECL in 60 Seconds
  • Ecolab provides water, hygiene, and infection prevention services.
  • Recurring on-site service revenue drives stability.
  • Economic slowdowns and valuation are the main risks.
  • Organic growth and operating margin are the key numbers.
What's inside this report
  • Ecolab provides water treatment, cleaning, sanitizing, and infection prevention products and services.
  • Customers include restaurants, hotels, healthcare, food processing, and industrial plants.
  • Service reps visit customers and dispense solutions on-site, creating a sticky relationship.
  • Digital water tools and data services are growing.
  • The equity debate is whether steady growth and margin gains justify a premium multiple.

Executive Summary

Ecolab's business is built on solving customer problems, not simply selling chemicals.

On-site service and dosing equipment integrate it into customers' processes.

Demand is resilient because sanitation and water management are essential and regulated.

Pricing and mix have improved margins, while data centers and industrial water use offer growth.

The realistic thesis: a high-quality compounder with recurring revenue, priced at a premium, where execution and steady end-market growth matter.

Industry & Market Backdrop

The broader competitive and macro environment ECL operates in — context a pure valuation table can't convey on its own.

Water scarcity and sustainability needs increase demand for water solutions.

Food safety and hygiene regulation support recurring demand.

Hospitality and restaurant traffic affect institutional volumes.

Industrial activity affects water and process solutions.

Raw material costs are managed through pricing.

Live Key Statistics

Pulled live from BriMindInvest's market-data pipeline at page load — the same feed that powers /analysis/ECL. Fields the pipeline doesn't return this load are omitted rather than shown blank.

Current Price
$269.98
Market Cap
$75.68B
Trailing P/E
36.29
Forward P/E
28.67
52-Week High
$309.27
52-Week Low
$243.15
Beta
0.89
Revenue Growth (YoY)
+9.7%
Operating Margin
+18.5%
Return on Equity
+22.0%
Debt / Equity
138.02
Dividend Yield
+1.08%

Business Overview

Global Institutional and Specialty for restaurants and hotels.

Global Industrial for water and process applications.

Global Healthcare and Life Sciences.

Pest elimination and other services.

Segment Deep Dive

A closer look at each reporting segment individually, rather than treating the business as a single undifferentiated revenue line.

Institutional and specialty

Serves hospitality, food service, and facilities with cleaning and sanitizing solutions. Traffic and pricing influence results.

Industrial

Provides water and process solutions to industrial plants. It includes data center cooling applications.

Healthcare and life sciences

Provides infection prevention and cleaning for hospitals and pharma. It has stable demand.

Capital Allocation & Balance Sheet Philosophy

How management has historically chosen to deploy cash — buybacks, dividends, R&D, and acquisitions — and what that reveals about capital discipline.

The company pays a growing dividend and repurchases shares.

Capital expenditure supports dispensing equipment and technology.

Balance sheet is investment grade.

Acquisitions add capabilities.

Management & Governance

Leadership, incentive alignment, and governance structure — factors that shape execution risk independent of the underlying business model.

Leadership emphasizes growth, margin, and returns.

Management sets multi-year targets for earnings growth.

Governance is conventional; review the proxy for details.

Maintaining pricing power while delivering value is key.

See exactly how we get ECL's fair-value range

Unlock the premium content below
Table: Method, Relevance, Implied Value
MethodRelevanceImplied Value
Our DCF ModelHigh
Our P/E BasedMedium
Our Book Value BasedMedium
Graham NumberMedium
PEG Ratio BasedLow
ROIC BasedMedium
FCF Yield BasedHigh

Forecast Revenue and Free Cash Flow

5-Year Monte Carlo Simulation

Included with a subscription or a one-time purchase of this Ecolab report:

  • Fair value from 7 methods, weighted by relevance to this business
  • 5-year financial forecast and DCF/earnings sensitivity grids
  • Decomposed AI Score, Monte Carlo simulation, and institutional/analyst data

$3.99 is less than one bad options trade — see the model before you commit real money. And it goes straight to the small team building this, not a hedge fund's marketing budget.

Bull Case vs. Bear Case

Bull Case
  • Pricing and volume grow steadily.
  • Margins keep expanding.
  • Water and data center applications grow.
  • Digital services scale.
  • Capital return continues.
Bear Case
  • Hospitality demand weakens.
  • Industrial activity slows.
  • Raw material costs rise.
  • Competition intensifies.
  • Premium valuation contracts.

Related Reports

In-depth reports for other names in Ecolab's comparable set.

Sherwin-Williams
SHW In-Depth Report
Air Products and Chemicals
APD In-Depth Report
Linde plc
LIN In-Depth Report
PPG Industries
PPG In-Depth Report
Cintas
CTAS In-Depth Report

4 catalysts and 4 risks we're tracking for ECL

Unlock the premium content below
Table: Catalyst, Expected Impact, Timeframe
CatalystExpected ImpactTimeframe

Included with a subscription or a one-time purchase of this Ecolab report:

  • Catalyst list, each tagged with expected impact and timing
  • Risk register scored by probability and severity
  • 4 key metrics to watch before the next earnings report

$3.99 is less than one bad options trade — see the model before you commit real money. And it goes straight to the small team building this, not a hedge fund's marketing budget.

What Would Change Our Mind?

Specific, falsifiable triggers — not vague sentiment — that would move us toward or away from the bull case above.

Would Turn Us More Bullish
  • Organic growth stays steady
  • Margins keep rising
  • Water solutions expand
Would Turn Us More Cautious
  • Demand softens across end markets
  • Costs squeeze margins
  • Premium multiple compresses

Competitive Positioning

Ecolab's moat is on-site service, scale, and customer integration.

Diversey, Solenis, Veolia, and specialty chemical makers compete in parts.

Regulatory expertise and service coverage are difficult to match.

The vulnerability is premium valuation and industrial cycles.

Investor Decision Framework

A process for using this report, not a recommendation — how to weigh valuation, scenario spread, and your own risk tolerance.

  • Own it if you want a stable, service-based compounder.
  • Skip it if you dislike premium multiples.
  • Track organic growth and margins.

The BriMindInvest Edge

Why this report is different from asking a general-purpose AI chatbot about the stock.

  • Every valuation number on this page is computed live from current market data through our own DCF, scoring, and Monte Carlo engines — not summarized or paraphrased from other analysts' reports the way a general chatbot would.
  • The relevance-weighted fair value, reverse-DCF market-implied growth, fundamentals-based Monte Carlo, and scenario tables above are proprietary calculations you cannot get by asking a general-purpose AI for "ECL fair value" — those answers come from web summaries of other people's price targets, not a live, disclosed-assumption model.
  • Our 1-year price-target model has a real, published backtest (see Model Track Record above where covered) — we show our work and our error rate rather than asserting accuracy.
  • Numbers here are refreshed every time you load the page, not cached from a training cutoff months or years in the past.

Data Sources & Methodology

Valuation, price, and financial-statistics data in this report are fetched live from our production market-data pipeline (Yahoo Finance and Finnhub) at the time you loaded this page. The AI Score is a percentile ranking against our full covered stock universe, recomputed nightly. The fundamentals-based Monte Carlo and Bull/Base/Bear scenarios randomize growth rate, discount rate, and terminal growth around the same disclosed DCF assumptions used in the valuation table — they are not derived from resampled historical stock returns. The secondary historical-volatility simulation (2,000 bootstrap paths, seeded for reproducibility) uses the stock's own historical monthly returns and is shown separately because it measures a different thing (volatility) than the fundamentals-based model (intrinsic value).

This report is for informational and educational purposes only and does not constitute financial, investment, or tax advice, or a recommendation to buy or sell any security. All valuation models, price targets, and simulations are estimates based on historical and current data; actual results will differ, potentially substantially. Investing involves risk, including loss of principal. See our full Methodology and Disclaimer.

Free vs. Premium: What You're Getting

Free Article
  • Narrative overview and general bull/bear framing
  • Headline price and basic company facts
  • No live valuation model, AI Score, or forecast table
This Premium Report
  • Relevance-weighted fair value range and reverse-DCF market-implied growth
  • 5-year financial forecast, DCF sensitivity grid, and Bull/Base/Bear scenario table
  • Fundamentals-based Monte Carlo and decomposed AI Score with sub-factor components
  • Real, published backtested accuracy where ECL is in our coverage set

Glossary of Key Terms

Plain-English definitions for the terms used throughout this report, for readers newer to equity valuation.

Dosing equipment
Equipment placed at customers to dispense chemicals accurately.
Organic growth
Growth excluding currency and acquisitions.
Infection prevention
Products and practices that reduce the spread of infections.

Frequently Asked Questions

What does Ecolab do?
It provides water, hygiene, and infection prevention solutions.
Who are its customers?
Restaurants, hotels, hospitals, food plants, and industries.
Does Ecolab pay a dividend?
Yes, and it has raised it for many years.
What is the main risk?
Economic slowdown and premium valuation.
ShareXLinkedInRedditFacebookWhatsApp

Unlock Full AI-Powered Analysis

Get AI prediction signals, unlimited stock comparisons, portfolio analytics, and personalized watchlists — free for 14 days, no credit card required.

Start Free TrialSign In

14-day free trial · No credit card required · Cancel anytime

Not ready to sign up? Get one free email a week instead.

Data sources & disclosures: Financial data and metrics cited in this article are sourced from company SEC filings, earnings releases, and investor relations materials. Market prices and fundamental data are provided by financial market data providers. Market size estimates and industry projections are sourced from industry research and analyst reports. Figures reflect information available at the time of writing and may have changed. AI scores and price targets are proprietary estimates — see our Methodology. This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Investing involves risk, including the possible loss of principal. Please read our full Disclaimer and consult a licensed financial adviser before making investment decisions.